Transient Retinal Artery Occlusion During Phacoemulsification Cataract
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Un-Explained Visual Loss Following Silicone Oil Removal
Roca et al. Int J Retin Vitr (2017) 3:26 DOI 10.1186/s40942-017-0079-6 International Journal of Retina and Vitreous ORIGINAL ARTICLE Open Access Un‑explained visual loss following silicone oil removal: results of the Pan American Collaborative Retina Study (PACORES) Group Jose A. Roca1, Lihteh Wu2* , Maria Berrocal3, Francisco Rodriguez4, Arturo Alezzandrini5, Gustavo Alvira6, Raul Velez‑Montoya7, Hugo Quiroz‑Mercado7, J. Fernando Arevalo8, Martín Serrano9, Luiz H. Lima10, Marta Figueroa11, Michel Farah10 and Giovanna Chico1 Abstract Purpose: To report the incidence and clinical features of patients that experienced un-explained visual loss following silicone oil (SO) removal. Methods: Multicenter retrospective study of patients that underwent SO removal during 2000–2012. Visual loss of 2 lines was considered signifcant. ≥ Results: A total of 324 eyes of 324 patients underwent SO removal during the study period. Forty two (13%) eyes sufered a signifcant visual loss following SO removal. Twenty three (7.1%) of these eyes lost vision secondary to known causes. In the remaining 19 (5.9%) eyes, the loss of vision was not explained by any other pathology. Eleven of these 19 patients (57.9%) were male. The mean age of this group was 49.2 16.4 years. Eyes that had an un-explained visual loss had a mean IOP while the eye was flled with SO of 19.6 6.9 mm± Hg. The length of time that the eye was flled with SO was 14.8 4.4 months. In comparison, eyes that± did not experience visual loss had a mean IOP of 14 7.3 mm Hg (p < 0.0002)± and a mean tamponade duration of 9.3 10.9 months (p < 0.0001). -
Evaluation of Phacoemulsification Cataract Surgery Outcomes After Penetrating Keratoplasty
Open Access Maced J Med Sci electronic publication ahead of print, published on December 20, 2019 as https://doi.org/10.3889/oamjms.2019.379 ID Design Press, Skopje, Republic of Macedonia Open Access Macedonian Journal of Medical Sciences. https://doi.org/10.3889/oamjms.2019.379 eISSN: 1857-9655 Basic and Clinical Medical Researches in Vietnam Evaluation of Phacoemulsification Cataract Surgery Outcomes After Penetrating Keratoplasty Le Xuan Cung1, Do Thi Thuy Hang1, Nguyen Xuan Hiep1, Do Quyet2, Than Van Thai3, Vu Thi Nga4, Nguyen Duy Bac2, Dinh Ngan Nguyen2* 1Vietnam National Institute of Ophthalmology, Hanoi, Vietnam; 2Vietnam Military Medical University (VMMU), Hanoi, Vietnam; 3NTT Hi-tech Institute, Nguyen Tat Thanh University, Ho Chi Minh City, Vietnam; 4Institute for Research and Development, Duy Tan University, 03 Quang Trung, Danang, Vietnam Abstract Citation: Cung LX, Hang DTT, Hiep NX, Quyet D, Thai BACKGROUND: Cataract is one of the reasons which causes impaired visual acuity (VA) of the eyes after TV, Nga VT, Bac ND, Nguyen DN. Evaluation of penetrating keratoplasy (PK), which can be treated by cataract surgery after PK or triple procedure. Cataract Phacoemulsification Cataract Surgery Outcomes After Penetrating Keratoplasty. Open Access Maced J Med Sci. surgery after PK has advantages that parameters of the eyes such as axial length, anterior chamber depth (ACD) https://doi.org/10.3889/oamjms.2019.379 as well as corneal curvature are stabilized after removing all sutures postoperatively, and intraocular lens (IOL) Keywords: Complicated Cataract; Corneal graft; power can be calculated correctly. Therefore, postoperative VA will be improved significantly. In Vietnam, there Penetrating Keratoplasty; Phacoemulsification have not been any study about cataract surgery after PK, therefore we conduct this research. -
Acute Hydrops Following Penetrating Keratoplasty in a Keratoconic Patient
Acute Hydrops following PK • Baradaran-Rafiee et al Iranian Journal of Ophthalmology • Volume 20 • Number 4 • 2008 Acute Hydrops following Penetrating Keratoplasty in a Keratoconic Patient Alireza Baradaran-Rafiee, MD1 • Manijeh Mahdavi, MD2 • Sepehr Feizi, MD3 Abstract Purpose: To report a case with history of penetrating keratoplasty (PK) for keratoconus that developed acute hydrops in the recipient and donor cornea Methods: A 46-year-old man, with history of bilateral keratoconus, who had undergone corneal transplantation in his left eye, presented with complaints of sudden visual reduction, photophobia, redness and pain of the left eye. Results: Review of his clinical course, slit-lamp biomicroscopy, laboratory evaluations including confocal microscopy and ultrasound biomicroscopy revealed acute hydrops in the graft. Second corneal transplantation was done for his left eye and pathologic examination confirmed the diagnosis. Conclusion: Acute hydrops can occur after PK in patients with keratoconus. Although this condition is not common, it should be considered as a differential diagnosis of graft rejection. Keywords: Acute Hydrops, Keratoconus, Corneal Transplantation Iranian Journal of Ophthalmology 2008;20(4):49-53 Introduction Keratoconus is a degenerative, One of the complications of advanced non-inflammatory disease of the cornea, with keratoconus is acute hydrops. Affected onset generally at puberty. It is progressive in patients suffer from acute visual loss with pain 20% of cases and can be treated by lamellar and photophobia. On slit-lamp examination, or penetrating keratoplasty (PK). Its incidence conjunctival hyperemia and diffuse corneal in general population is reported to be about edema with intrastromal cystic spaces are 1/2000.1 Changes in corneal collagen visible. -
06 35938Nys130220 52
Changes in macular perfusion after Phacoemulsification surgery Sabah Abd El Azeem Soud, Doaa El Said El Badrawy, Nesma Sayed Mohammed Department of Ophthalmology, Alzahraa University Hospital, AL-Azhar University, Cairo, Egypt [email protected] Abstract: Background: Optical coherence tomography angiography (OCT-A) is a non-invasive, non-dye-based imaging modality that is used worldwide in the daily practice of ophthalmology. OCTA enhances our understanding of retinal diseases and retinal vascular changes. Objective: To evaluate, by means of optical coherence tomography angiography (OCTA) the changes that may occur at the macular vessels after phacoemulsification surgery and if these changes can affect the post-operative visual acuity. Patients and Methods: It was a prospective study carried out at Al Zahraa University Hospital on 30 eyes of 21 Patients with senile cataract were included. Retina vessel density at the macular area was checked by OCT A at 1 week, 1 month, and 3 months after cataract surgery. Results: Thirty eyes (21 patients) were included in the final analysis. There was a significant increase in retinal vessel density at the macular area after the cataract surgery, repeated-measures which extended to the end of the follow-up period. At 3 months postoperatively, Appearance of hyper reflective retinal spots post operatively was also noted. Conclusions: Macular vessel density increased after phacoemulsification surgery. These changes seem not to affect visual acuity. Whether these changes will persist over a longer period of time, that still needs to be studied. [Sabah Abd El Azeem Soud, Doaa El Said El Badrawy, Nesma Sayed Mohammed. Changes in macular perfusion after Phacoemulsification surgery. -
Intraocular Pressure During Phacoemulsification
J CATARACT REFRACT SURG - VOL 32, FEBRUARY 2006 Intraocular pressure during phacoemulsification Christopher Khng, MD, Mark Packer, MD, I. Howard Fine, MD, Richard S. Hoffman, MD, Fernando B. Moreira, MD PURPOSE: To assess changes in intraocular pressure (IOP) during standard coaxial or bimanual micro- incision phacoemulsification. SETTING: Oregon Eye Center, Eugene, Oregon, USA. METHODS: Bimanual microincision phacoemulsification (microphaco) was performed in 3 cadaver eyes, and standard coaxial phacoemulsification was performed in 1 cadaver eye. A pressure transducer placed in the vitreous cavity recorded IOP at 100 readings per second. The phacoemulsification pro- cedure was broken down into 8 stages, and mean IOP was calculated across each stage. Intraocular pressure was measured during bimanual microphaco through 2 different incision sizes and with and without the Cruise Control (Staar Surgical) connected to the aspiration line. RESULTS: Intraocular pressure exceeded 60 mm Hg (retinal perfusion pressure) during both standard coaxial and bimanual microphaco procedures. The highest IOP occurred during hydrodissection, oph- thalmic viscosurgical device injection, and intraocular lens insertion. For the 8 stages of the phaco- emulsification procedure delineated in this study, IOP was lower for at least 1 of the bimanual microphaco eyes compared with the standard coaxial phaco eye in 4 of the stages (hydro steps, nu- clear disassembly, irritation/aspiration, anterior chamber reformation). CONCLUSION: There was no consistent difference in IOP between the bimanual microphaco eyes and the eye that had standard coaxial phacoemulsification. Bimanual microincision phacoemul- sification appears to be as safe as standard small incision phacoemulsification with regard to IOP. J Cataract Refract Surg 2006; 32:301–308 Q 2006 ASCRS and ESCRS Bimanual microincision phacoemulsification, defined as capable of insertion through these microincisions become cataract extraction through 2 incisions of less than 1.5 mm more widely available. -
Red Spot • Important Is the Time Period from the Event • Therapy Is Reasonable If the Patient Is Treated Within the First 6 Hours
ACUTE VISUAL LOSS KAROLÍNA SKORKOVSKÁ VISUAL LOSS • CENTRAL RETINAL ARTERY OCCLUSION • CENTRAL RETINAL VEIN OCCLUSION • RETINAL DETACHMENT • VITREOUS HAEMORRHAGE • OPTIC NEURITIS • AION VISUAL LOSS - PATIENT´S HISTORY • UNILATERAL / BILATERAL • SUDDEN / SLOWLY PROGRESSIVE • PAIN • COMPLAINTS (FOGGY VISION, FLOATERS, CURTAIN…) • OTHER SYMPTOMS (FEVER, WEIGHT LOSS, REFRACTIVE CHANGE, …) CATARACT • SLOWLY PROGRESSIVE VISUAL LOSS • FOGGY VISION • CHANGE IN REFRACTIVE ERROR (INDEX MYOPIA) • CATARACT VISIBLE ON SLIT LAMP • THERAPY: CATARACT EXTRACTION RETINAL ARTERY OCCLUSION • SUDDEN, UNILATERAL, PAINLESS LOSS OF VISION • VISUAL ACUITY MAY BE „NO LIGHT PERCEPTION“ • BRANCH / CENTRAL RETINAL ARTERY OCCLUSION • RETINAL ISCHEMIA WITH CHERRY RED SPOT • IMPORTANT IS THE TIME PERIOD FROM THE EVENT • THERAPY IS REASONABLE IF THE PATIENT IS TREATED WITHIN THE FIRST 6 HOURS RETINAL ARTERY OCCLUSION - COMPLICATIONS • POOR PROGNOSIS • PERMANENT LOSS OF VISION • OPTIC DISC ATROPHY • NEOVASCULARISATION GLAUCOMA RETINAL ARTERY OCCLUSION - THERAPY • LOWERING OF INTRAOCULAR PRESSURE • RETROBULBAR INJECTION OF VASODILATORS • PARACENTHESIS • SYSTEMIC TROMBOLYSIS (DEPARTMENT OF INTERNAL MEDICINE) • CHECK-UP OF RISK FACTORS OF ISCHEMIA / TROMBOSIS RETINAL VEIN OCCLUSION • SUDDEN, PAINLESS, UNILATERAL VISUAL LOSS • VISUAL ACUITY USUALLY NOT AS MUCH AFFECTED AS IN CRAO • BRANCH / CENTRAL RETINAL VEIN OCCLUSION • OFTEN CARDIOVASCULAR RISK FACTORS (HYPERTENSION, DIABETES, HYPERLIPIDEMIA, ISCHEMIC HEART DISEASE,…) • RETINAL HAEMORHAGES, OPTIC NERVE HEAD OEDEMA, RETINAL -
A Review of Central Retinal Artery Occlusion: Clinical Presentation And
Eye (2013) 27, 688–697 & 2013 Macmillan Publishers Limited All rights reserved 0950-222X/13 www.nature.com/eye 1 2 1 2 REVIEW A review of central DD Varma , S Cugati , AW Lee and CS Chen retinal artery occlusion: clinical presentation and management Abstract Central retinal artery occlusion (CRAO) is an that in turn place an individual at risk of future ophthalmic emergency and the ocular ana- cerebral stroke and ischaemic heart disease. logue of cerebral stroke. Best evidence reflects Although analogous to a cerebral stroke, there that over three-quarters of patients suffer is currently no guideline-endorsed evidence for profound acute visual loss with a visual acuity treatment. Current options for therapy include of 20/400 or worse. This results in a reduced the so-called ‘standard’ therapies, such as functional capacity and quality of life. There is sublingual isosorbide dinitrate, systemic also an increased risk of subsequent cerebral pentoxifylline or inhalation of a carbogen, stroke and ischaemic heart disease. There are hyperbaric oxygen, ocular massage, globe no current guideline-endorsed therapies, compression, intravenous acetazolamide and although the use of tissue plasminogen acti- mannitol, anterior chamber paracentesis, and vator (tPA) has been investigated in two methylprednisolone. None of these therapies randomized controlled trials. This review will has been shown to be better than placebo.5 describe the pathophysiology, epidemiology, There has been recent interest in the use of and clinical features of CRAO, and discuss tissue plasminogen activator (tPA) with two current and future treatments, including the recent randomized controlled trials on the 1Flinders Comprehensive use of tPA in further clinical trials. -
Five-Year Outcomes of Trabeculectomy and Phacotrabeculectomy
Open Access Original Article DOI: 10.7759/cureus.12950 Five-Year Outcomes of Trabeculectomy and Phacotrabeculectomy Danny Lam 1 , David Z. Wechsler 1, 2 1. Ophthalmology, University of Sydney, Sydney, AUS 2. Ophthalmology, Macquarie University, Sydney, AUS Corresponding author: Danny Lam, [email protected] Abstract Purpose The purpose of this study is to examine five-year outcomes of trabeculectomy and compare the stand-alone procedure when combined with phacoemulsification. Patients and methods This study included 123 eyes of 109 patients, with 79 patients in the trabeculectomy group and 44 patients in the phacotrabeculectomy group. Non-randomized comparative cohort study with data collected retrospectively from an existing database compiled by a single surgeon operating in Sydney, Australia from 2007 to 2019. The primary outcome measure was intraocular pressure. Secondary outcome measures were a number of glaucoma medications, treatment success rates, best-corrected visual acuity, bleb morphology, post-operative complications, and re-operation rate. Results The mean intraocular pressure was 10.6 ± 2.7 mm Hg in the trabeculectomy group (pre-operative mean intraocular pressure of 28.0 ± 9.8) and 12.0 ± 3.0 mm Hg in the phacotrabeculectomy group (pre-operative mean intraocular pressure of 23.4 ± 7.9) after five years (P = 0.052). The number of glaucoma medications required was 0.3 ± 0.7 in the trabeculectomy group (pre-operative mean of 3.7 ± 1.1) and 1.3 ± 1.2 in the phacotrabeculectomy group (pre-operative mean of 3.1 ± 1.0, P < 0.001). Conclusions Intraocular pressure reduction post-operatively over five years was similar between trabeculectomy and phacotrabeculectomy as determined by mean intraocular pressure, and intraocular pressure reduction from baseline. -
Retinal Microvascular Alterations After Phacoemulsification in Patients With
Retinal microvascular alterations after phacoemulsication in patients with diabetes evaluated using optical coherence tomography angiography Le Feng Shanghai Tenth People's Hospital https://orcid.org/0000-0002-2148-7423 Guliqiwaer Azhati Shanghai Tenth People's Hospital Tingting Li Shanghai Tenth People's Hospital Fang Liu ( [email protected] ) https://orcid.org/0000-0003-2844-2225 Research article Keywords: retinal microvasculature, phacoemulsication, diabetes, OCT angiography Posted Date: August 26th, 2019 DOI: https://doi.org/10.21203/rs.2.13588/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/13 Abstract Purpose: To quantify changes in retinal microvasculature in diabetic patients after phacoemulsicatio by using optical coherence tomography angiography (OCTA). Methods: Macular thickness(MT), supercial capillary plexus (SCP), deep capillary plexuses (DCP) and foveal avascular zone (FAZ) measurements of the 3×3 mm macular images were obtained by OCTA at baseline, 1 day,1 week, 1 month, and 3 months after cataract surgery in diabetic and non- diabetic patients. Results: There was a signicant increase in MT at 1 month and 3 months after surgery in both groups (all P<0.05), but no signicant difference between the two groups (p= 0.217). At 3 months postoperatively, the SCP increase was signicantly higher compared with baseline in diabetic group (P<0.05). The MT and SCP was negatively correlated with logMAR best corrected visual acuity(BCVA), while the FAZ area and perimeter were positively correlated with logMAR BCVA in diabetic group. Conclusions: Cataract surgery can increase macular thickness in both diabetic and non- diabetic patients, and also increase the SCP in diabetic patients. -
Acute Visual Loss 5 Cédric Lamirel , Nancy J
Acute Visual Loss 5 Cédric Lamirel , Nancy J. Newman , and Valérie Biousse Abstract Visual loss is a common symptom in neurologic emergencies. Although ocular causes of visual loss are usually identifi ed by eye care specialists, many patients appear in an emergency department or a neurologist’s offi ce when the ocular examination is normal or when it suggests a neurologic disorder. Indeed, many causes of monocular or binocular acute visual loss may reveal or precede a neurologic process. In this situation, a quick and simple clinical examination done at bedside in the emergency department allows the neurologist to localize the lesion and determine whether an urgent neurologic workup or further ophthalmologic consultation is necessary. Keywords Central retinal artery occlusion • Funduscopic examination • Optic neuropathy • Retinal emboli • Visual fi eld • Visual loss Acute vision changes typically precipitate emer- gency consultation. Although ocular causes are usually identifi ed by eye care specialists, many patients appear in an emergency department or a C. Lamirel , MD neurologist’s offi ce when the ocular examination Service d’ophtalmologie , Fondation Ophtalmologique is normal or when it suggests a neurologic disor- Adolphe Rothschild , Paris , France der. Indeed, many causes of monocular or binoc- e-mail: [email protected] ular acute visual loss may reveal or precede a N. J. Newman , MD • V. Biousse, MD () neurologic process. In this situation, a quick and Neuro-Ophthalmology Unit , simple clinical examination done at bedside in Emory University School of Medicine , Atlanta , GA , USA the emergency department allows the neurologist e-mail: [email protected]; [email protected] to localize the lesion and determine whether an K.L. -
IOC Mednick: Challenging Surgical Cases
Top 5 Pearls to Consider When Implanting Advanced Technology IOLs in Patients With Unusual Circumstances Zale D. Mednick, BA Guillermo Rocha, MD, FRCSC ’ Pearl #1: The Use of a Toric Multifocal Intraocular Lens (IOL) in the Management of Hyperopic Astigmatism Background The mainstay of treatment for those with hyperopic astigmatism who wish to bypass the need for glasses or contacts has traditionally been laser treatment. Both hyperopic laser in situ keratomileusis (LASIK) and photorefractive keratotomy (PRK) have been used to correct hyperopic astigmatism. Although LASIK can provide promising results for a portion of patients with hyperopic eyes, it becomes less effective when dealing with more exaggerated degrees of hyperopia. Refractive results are much more successful for low diopter (D) hyperopia, with a drop in efficacy starting at + 4.00 to + 5.00 D.1 Esquenazi and Mendoza2 reported that when LASIK is performed on eyes with >5.00 D of hyperopia, both the safety profile of the procedure and the refractive outcomes dramatically decline, coinciding with decreased corrected distance visual acuity (CDVA). Choi and Wilson3 echoed this notion, citing a 2-line drop in CDVA when LASIK was used to treat hyperopia of 5.00 to 8.75 D. This is in stark contrast to the results achieved by LASIK to improve myopia, where corrections are feasible for a far greater range of refractions. Part of the reason that hyperopia is less amenable to correction of higher diopter errors may owe to the fact that larger ablation zones are needed to achieve better refractive results.4 The optimal size of the ablation zone for hyperopic LASIK is >5.5 mm,1 and as such, more corneal alteration is required. -
Approach to Acute Visual Loss
APPROACH TO ACUTE VISUAL LOSS 11 : 2 Satish Khadilkar, Pramod Dhonde, Mumbai INTRODUCTION Acute visual loss is common in clinical practice. The symptom is very disturbing to patients and requires rapid clinical analysis and therapy, as it can be associated with significant morbidity. Etiologies of acute visual impairment range from retina to the occipital cortex, resulting in a plethora of presentations. For example in a case of retinal disease patient may feel as if a curtain is rising or dropping and in cases of occipital lesions, patients may give history of bumping into the objects without realization. Also, patients tend to mistake diplopia for visual loss, which needs careful analysis. Acute visual loss could either be monocular or binocular. Monocular loss is often related to local eye pathologies as glaucoma, uveitis, retinitis or neurological diseases like optic neuritis (ON) and anterior ischemic optic neuropathy (AION). Binocular diseases are usually associated with lesions affecting structures such as optic chiasma, lateral geniculate body, occipital radiations and occipital cortex. Pain is an important association of visual loss. Painful visual impairment is seen in ON, Tolosa Hunt Syndrome, orbital apex syndrome, pituitary apoplexy and glaucoma. On the other hand, diseases of the optic tracts, radiations, occipital cortex and AION tend to be painless. The natural history of the visual impairment is helpful in the differential diagnosis. Transient visual deficit is seen in vascular diseases, demyelinations, raised intracranial tension and hyper coagulable states. Lasting deficits are seen with, strokes, tumors and AION. Following cases will illustrate various clinical situations of acute visual impairment, encountered by clinicians.